Trekking Through the Latest Updates for ROS1-Targeted Therapies
Trekking Through the Latest Updates for ROS1-Targeted Therapies is organized by Physicians' Education Resource, LLC (PER).
Release Date: January 31, 2023
Expiration Date: January 31, 2024
Description:
This Burst CME: Trekking Through the Latest Updates for ROS1-Targeted Therapies is an interview-based program in which an expert discusses the current and emerging therapeutic options for patients with ROS1-positive non–small cell lung cancer (NSCLC). Possible adverse events and mitigation strategies are also discussed. This will be presented in a multimedia format, including audio interviews integrated into text-based elements.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Describe testing methods and relevant targets that may be used to inform clinical decisions in patients with NSCLC and fusions of ROS1 or NTRK
• Interpret current efficacy and safety data from trials that leveraged precision testing strategies among patients with advanced NSCLC
• Explain emerging therapies that target ROS1 and NTRK in development to manage patients with advanced NSCLC.